Charcot spinal arthropathy (CSA), a destructive spinal pathology, is seen in patients with impaired sensation. Superimposed infection in the affected spinal segments can lead to a challenge in the diagnosis and management. Spinal cord injury (SCI) is the leading cause of CSA as persons with SCI have significantly impaired sensation. Though infection of the CSA is rare, SCI persons are prone to superimposed infection of the Charcot spine. We report atypical presentations of three cases of CSA with superimposed infection.

Case descriptions

A 47-year-old male with complete T7–8 SCI developed symptoms suggestive of infection and CSA. He was managed with a posterior vertebral column resection (PVCR) of T12 and intravenous antibiotics as the intraoperative culture showed the growth of E. coli and Pseudomonas. A 26-year-old male with T12 complete paraplegia, post status post open reduction and internal fixation with subsequent implants removal developed infection and CSA over the pseudo-arthrotic lesion with destruction of T12 and L1 vertebrae and an external fistulous track. He was managed with debridement and anterior column T11–L1 reconstruction with a Titanium cage and four-rod pedicle screw stabilization construct. A 25-year-old male with complete paraplegia with CSA at L4–S1. He underwent PVCR of L5 and L3–S2 posterior stabilization. The intraoperative culture and histopathology were suggestive of tuberculous infection.


Pyogenic or tubercular infection of CSA should be considered as a diagnostic possibility in persons with SCI who are more prone to infections. The management includes aggressive debridement and circumferential fusion along with appropriate medications to control the infection.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Barrey C, Massourides H, Cotton F, Perrin G, Rode G. Charcot spine: two new case reports and a systematic review of 109 clinical cases from the literature. Ann Phys Rehabil Med. 2010;53:200–20.

  2. 2.

    Moreau S, Lonjon G, Jameson R, Judet T, de Loubresse CG. Do all charcot spine require surgery? Orthop Traumatol Surg Res. 2014;100:779–84.

  3. 3.

    Ledbetter LN, Salzman KL, Sanders RK, Shah LM. Spinal neuroarthropathy: pathophysiology, clinical and imaging features, and differential diagnosis. Radiographics. 2016;36:783–99.

  4. 4.

    Jacobs WB, Bransford RJ, Bellabarba C, Chapman JR. Surgical management of Charcot spinal arthropathy: a single-center retrospective series highlighting the evolution of management. J Neurosurg Spine. 2012;17:422–31.

  5. 5.

    Capps E, Linnau KF, Crane DA. Beyond broken spines–what the radiologist needs to know about late complications of spinal cord injury. Insights Imaging. 2015;6:111–22.

  6. 6.

    D’Anastasi M, Birkenmaier C, Schmidt GP, Wegener B, Reiser MF, Baur-Melnyk A. Correlation between vacuum phenomenon on CT and fluid on MRI in degenerative disks. Am J Roentgenol. 2011;197:1182–9.

  7. 7.

    Morita M, Miyauchi A, Okuda S, Oda T, Yamamoto T, Iwasaki M. Charcot spinal disease after spinal cord injury. J Neurosurg Spine. 2008;9:419–26.

  8. 8.

    Cruse JM, Keith JC, Bryant ML, Lewis RE. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol Res. 1996;15:306.

  9. 9.

    Aebli N, Pötzel T, Krebs J. Characteristics and surgical management of neuropathic (Charcot) spinal arthropathy after spinal cord injury. Spine J. 2014;14:884–91.

  10. 10.

    Mikawa Y, Watanabe R, Yamano Y, Morn S. Infected Charcot spine following spinal cord injury. Spine. 1989;14:892–5.

  11. 11.

    Pritchard JC, Coscia MF. Infection of a Charcot spine. A case report. Spine. 1993;18:764–7.

  12. 12.

    Suda Y, Saito M, Shioda M, Kato H, Shibasaki K. Infected charcot spine. Spinal Cord. 2005;43:256.

  13. 13.

    Okulicz JF, Lloyd BA, Krause JO, Conger NG. Mycobacterium tuberculosis infection of a presumed Charcot joint. South Med J. 2005;98:924–6.

  14. 14.

    Grassner L, Geuther M, Mach O, Bühren V, Vastmans J, Maier D. Charcot spinal arthropathy: an increasing long-term sequel after spinal cord injury with no straightforward management. Spinal Cord Ser Cases. 2015;1:15022.

  15. 15.

    Shen FH, Harper M, Foster WC, Marks I, Arlet V. A novel “four-rod technique” for lumbo-pelvic reconstruction: theory and technical considerations. Spine. 2006;31:1395–401.

  16. 16.

    Shen FH, Qureshi R, Tyger R, Lehman R, Singla A, Shimer A, et al. Use of the “Dual Construct” for the management of complex spinal reconstructions. Spine J. 2018;18:482–90.

  17. 17.

    Allen RT, Lee YP, Stimson E, Garfin SR. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis. Spine. 2007;32:2996–3006.

  18. 18.

    Drazin D, Choi E, Garcia A, Rustagi T. Bone morphogenic proteins are a good choice for select spinal surgeries and merit further research. J Spine Surg. 2017;3:119.

  19. 19.

    Conterno LO, da Silva, Filho CR. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev. 2009;3:CD004439.

Download references

Author information


  1. Indian Spinal Injuries center, Sector C, Vasant Kunj, New Delhi, India, 110070

    • Phani krishna karthik Yelamarthy
    • , Tarush Rustagi
    • , Rajat Mahajan
    • , Vishwajeet Singh
    • , Kalidutta Das
    • , Murari Lal Bansal
    • , Bibhudendu Mohapatra
    •  & Harvinder Singh Chhabra


  1. Search for Phani krishna karthik Yelamarthy in:

  2. Search for Tarush Rustagi in:

  3. Search for Rajat Mahajan in:

  4. Search for Vishwajeet Singh in:

  5. Search for Kalidutta Das in:

  6. Search for Murari Lal Bansal in:

  7. Search for Bibhudendu Mohapatra in:

  8. Search for Harvinder Singh Chhabra in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Tarush Rustagi.

About this article

Publication history